Brink Therapeutics

📍 Paris, France🗓 Founded 2024👥 10 employees💰 Last funded Feb 2025
Biotechnology Research🌐 brinktx.com
Website LinkedIn
Brink Therapeutics is developing next-generation recombinases — ultra-precise and efficient enzymes that surpass CRISPR-Cas9. We aim to revolutionize Cell and Gene therapies, enabling large-scale production to treat cancer, genetic disorders, and other diseases.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2024
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
France
2
Frequently asked questions
Who invested in Brink Therapeutics?
Brink Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Brink Therapeutics last raise funding?
The most recent investment in Brink Therapeutics recorded on gritt.io was in February 2025.
When was Brink Therapeutics founded?
Brink Therapeutics was founded in 2024.
What industry is Brink Therapeutics in?
Brink Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Brink Therapeutics based?
Brink Therapeutics is headquartered in Paris, France.